Inhibiting tumor growth of colorectal cancer by blocking the expression of vascular endothelial growth factor receptor 3 using interference vector-based RNA interference

International Journal of Molecular Medicine

Volumn 25, Issue 1, 2010, Pages 59-64

  Lui, Zhicheng ^a,b   Ma, Qiang ^b   Wang, Xianghui ^b   Zhang, Youcheng ^a  

^a LANZHOU UNIVERSITY   (China)

^b LANZHOU GENERAL HOSPITAL   (China)

Author keywords

Colorectal cancer; Proliferation; RNA interference; Vascular endothelial growth factor receptor 3

Indexed keywords

SMALL INTERFERING RNA; VASCULOTROPIN RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPHANGIOGENESIS; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; RNA SEQUENCE; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; LYMPHANGIOGENESIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; RNA INTERFERENCE; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 70549112947     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000313     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
2. Alitalo K and Carmeliet P: Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1: 219-227, 2002.
3. Pepper MS, Tille JC, Nisato R and Skobe M: Lymphangiogenesis and tumor metastasis. Cell Tissue Res 314: 167-177, 2003.
4. Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Ylä-Herttuala S, Jäättelä M and Alitalo K: Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 61:1786-1790, 2001.
5. Mattila MM, Ruohola JK, Karpanen T, Jackson DG, Alitalo K and Härkönen PL: VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer 98: 946-951, 2002.
6. Stacker SA, Caesar C, Baldwin ME, et al: VEGFD promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7: 151-152, 2001.
7. Skobe M, Hawighorst T, Jackson DG, et al: Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7: 192-198, 2001.
8. He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T and Alitalo K: Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor-3 signalling. J Natl Cancer Inst 5: 819-825, 2002.
9. Pytowski B, Goldman J, Persaud K, et al: Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 97: 14-21, 2005.
10. He Y, Rajantie I, Pajusola K, et al: Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65: 4739-4746, 2005.
11. Nilsson I, Rolny C, Wu Y, et al: Vascular endothelial growth factor receptor-3 in hypoxia-induced vascular development. FASEB J 18:1507-1515, 2004.
12. Valtola R, Salven P, Heikkilä P, et al: VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 154:1381-1390, 1999.
13. Kubo H, Fujiwara T, Jussila L, et al: Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 96: 546-553, 2000.
14. Elbashir SM, Harborth J, Weber K and Tuschl T: Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213, 2002.
15. Dumont DJ, Jussila L, Taipale J, et al: Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282: 946-949, 1998.
16. Chen F, Takenaka K, Ogawa E, Yanagihara K, Otake Y, Wada H and Tanaka F: Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer. Clin Cancer Res 10: 8548-8553, 2004.
17. Partanen TA, Arola J, Saaristo A, et al: VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 14: 2087-2096, 2000.
18. Shida A, Fujioka S, Kobayashi K, Ishibashi Y, Nimura H, Mitsumori N and Yanaga K: Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma. Int J Clin Oncol 11: 38-43, 2006.
19. Kitadai Y, Kodama M, Cho S, et al: Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes. Int J Cancer 115: 388-392, 2005.
20. Padera TP, Ancukiewicz M, Hoshida T, Fukumura D and Jain RK: Anti-VEGFR-3 therapy and lymph node metastasis. Cancer Res 67: 5055, 2007.
21. He XW, Yu X, Liu T, Yu SY and Chen DJ: Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice. Chin Med J 121: 439-444, 2008.
22. Wang SC, Liu H, Ren LF, Pan YF and Zhang YD: Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA Interference. Neoplasia 10: 399-407, 2008.
23. Ishikawa M, Kitayama J, Kazama S and Nagawa H: Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma. Jpn J Clin Oncol 33: 21-27, 2003.
24. Laakkonen P, Waltari M, Holopainen T, et al: Vascular endothelial growth factor receptor 3 (VEGFR-3) is involved in tumor angiogenesis and growth. Cancer Res 67: 593-599, 2007.
25. Onogawa S, Kitadai Y, Amioka T, et al: Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in early gastric carcinoma: correlation with clinicopathological parameters. Cancer Lett 226: 85-90, 2005.